Literature DB >> 28220025

Management of Cancer in the Older Age Person: An Approach to Complex Medical Decisions.

María Vallet-Regí1,2, Miguel Manzano3,2, Leocadio Rodriguez-Mañas4,5, Marta Checa López6, Matti Aapro7, Lodovico Balducci8.   

Abstract

The management of cancer in older aged people is becoming a common problem due to the aging of the population. There are many variables determining the complex situation that are interconnected. Some of them can be assessed, such as risk of mortality and risk of treatment complications, but many others are still unknown, such as the course of disease, the host-related factors that influence cancer aggressiveness, and the phenotype heralding risk of permanent treatment-related damage.This article presents a dynamic and personalized approach to older people with cancer based on our experience on aging, cancer, and their biological interactions. Also, novel treatments and management approaches to older individuals, based on their functional age and their social and emotional needs, are thoughtfully explored here. The Oncologist 2017;22:335-342 IMPLICATIONS FOR PRACTICE: The goal of this article is to suggest a practical approach to complexity, a clinical situation becoming increasingly common with the aging of the population. Beginning with the analysis of two clinical cases, the authors offer an algorithm for approaching cancer in the older person that involves the assessment of life expectancy without cancer, the risk that cancer might compromise a patient's survival, function, or quality of life, and the potential benefits and risks of the treatments based on a clinical evaluation. The authors then review possible laboratory assessment of functional age and the importance of rapid-learning databases in the study of cancer and age. © AlphaMed Press 2017.

Entities:  

Keywords:  Aging and Cancer; Complexity of Cancer in the Elderly; Geriatric Oncology; Personalized Treatment

Mesh:

Year:  2017        PMID: 28220025      PMCID: PMC5344648          DOI: 10.1634/theoncologist.2016-0276

Source DB:  PubMed          Journal:  Oncologist        ISSN: 1083-7159


  83 in total

1.  Predicting chemotherapy toxicity in older adults with cancer: a prospective multicenter study.

Authors:  Arti Hurria; Kayo Togawa; Supriya G Mohile; Cynthia Owusu; Heidi D Klepin; Cary P Gross; Stuart M Lichtman; Ajeet Gajra; Smita Bhatia; Vani Katheria; Shira Klapper; Kurt Hansen; Rupal Ramani; Mark Lachs; F Lennie Wong; William P Tew
Journal:  J Clin Oncol       Date:  2011-08-01       Impact factor: 44.544

2.  Medicine and the arts. L'incendio di Borgo. Commentary.

Authors:  Ligia J Dominguez
Journal:  Acad Med       Date:  2009-09       Impact factor: 6.893

3.  Effect of Pretreatment Renal Function on Treatment and Clinical Outcomes in the Adjuvant Treatment of Older Women With Breast Cancer: Alliance A171201, an Ancillary Study of CALGB/CTSU 49907.

Authors:  Stuart M Lichtman; Constance T Cirrincione; Arti Hurria; Aminah Jatoi; Maria Theodoulou; Antonio C Wolff; Julie Gralow; Daniel E Morganstern; Gustav Magrinat; Harvey Jay Cohen; Hyman B Muss
Journal:  J Clin Oncol       Date:  2016-01-11       Impact factor: 44.544

4.  Social Frailty in Community-Dwelling Older Adults as a Risk Factor for Disability.

Authors:  Hyuma Makizako; Hiroyuki Shimada; Kota Tsutsumimoto; Sanyoon Lee; Takehiko Doi; Sho Nakakubo; Ryo Hotta; Takao Suzuki
Journal:  J Am Med Dir Assoc       Date:  2015-10-09       Impact factor: 4.669

5.  Frailty in older adults: evidence for a phenotype.

Authors:  L P Fried; C M Tangen; J Walston; A B Newman; C Hirsch; J Gottdiener; T Seeman; R Tracy; W J Kop; G Burke; M A McBurnie
Journal:  J Gerontol A Biol Sci Med Sci       Date:  2001-03       Impact factor: 6.053

6.  Evaluation of a pharmacist-led medication assessment used to identify prevalence of and associations with polypharmacy and potentially inappropriate medication use among ambulatory senior adults with cancer.

Authors:  Ginah Nightingale; Emily Hajjar; Kristine Swartz; Jocelyn Andrel-Sendecki; Andrew Chapman
Journal:  J Clin Oncol       Date:  2015-03-23       Impact factor: 44.544

7.  Improving the Evidence Base for Treating Older Adults With Cancer: American Society of Clinical Oncology Statement.

Authors:  Arti Hurria; Laura A Levit; William Dale; Supriya G Mohile; Hyman B Muss; Louis Fehrenbacher; Allison Magnuson; Stuart M Lichtman; Suanna S Bruinooge; Enrique Soto-Perez-de-Celis; William P Tew; Michael A Postow; Harvey J Cohen
Journal:  J Clin Oncol       Date:  2015-07-20       Impact factor: 44.544

Review 8.  Frailty: a common pathway in aging and cancer.

Authors:  Lodovico Balducci
Journal:  Interdiscip Top Gerontol       Date:  2013-01-17

9.  Epigenome-wide scans identify differentially methylated regions for age and age-related phenotypes in a healthy ageing population.

Authors:  Jordana T Bell; Pei-Chien Tsai; Tsun-Po Yang; Ruth Pidsley; James Nisbet; Daniel Glass; Massimo Mangino; Guangju Zhai; Feng Zhang; Ana Valdes; So-Youn Shin; Emma L Dempster; Robin M Murray; Elin Grundberg; Asa K Hedman; Alexandra Nica; Kerrin S Small; Emmanouil T Dermitzakis; Mark I McCarthy; Jonathan Mill; Tim D Spector; Panos Deloukas
Journal:  PLoS Genet       Date:  2012-04-19       Impact factor: 5.917

10.  Evidence for the free radical/oxidative stress theory of ageing from the CHANCES consortium: a meta-analysis of individual participant data.

Authors:  Ben Schöttker; Hermann Brenner; Eugène H J M Jansen; Julian Gardiner; Anne Peasey; Růžena Kubínová; Andrzej Pająk; Roman Topor-Madry; Abdonas Tamosiunas; Kai-Uwe Saum; Bernd Holleczek; Hynek Pikhart; Martin Bobak
Journal:  BMC Med       Date:  2015-12-15       Impact factor: 8.775

View more
  8 in total

1.  Pretreatment neutrophil/lymphocyte, platelet/lymphocyte, lymphocyte/monocyte, and neutrophil/monocyte ratios and outcome in elderly breast cancer patients.

Authors:  B Losada; J A Guerra; D Malón; C Jara; L Rodriguez; S Del Barco
Journal:  Clin Transl Oncol       Date:  2018-11-30       Impact factor: 3.405

2.  Breast cancer, placing drug interactions in the spotlight: is polypharmacy the cause of everything?

Authors:  José Alberto Domínguez-Alonso; David Conde-Estévez; David Bosch; Maria Pi-Figueras; Ignacio Tusquets
Journal:  Clin Transl Oncol       Date:  2020-05-24       Impact factor: 3.405

Review 3.  Predicting Life Expectancy for Older Adults with Cancer in Clinical Practice: Implications for Shared Decision-making.

Authors:  Haydee Cristina Verduzco-Aguirre; Carolina Gomez-Moreno; Yanin Chavarri-Guerra; Enrique Soto-Perez-de-Celis
Journal:  Curr Oncol Rep       Date:  2019-06-25       Impact factor: 5.075

4.  Metaplastic Matrix-Producing Carcinoma and Apocrine Lobular Carcinoma In Situ Associated with Microglandular Adenosis: A Unique Case Report.

Authors:  Nektarios Koufopoulos; Dionysios Dimas; Foteini Antoniadou; Kyparissia Sitara; Dimitrios Balalis; Ioannis Boutas; Alina Roxana Gouloumis; Adamantia Kontogeorgi; Lubna Khaldi
Journal:  Diagnostics (Basel)       Date:  2022-06-13

5.  Evolution of older patients diagnosed with early breast cancer in Spain between 1998 and 2001 included in El Alamo III project.

Authors:  Mª D Torregrosa; M J Escudero; I Paredero; E Carrasco; B Bermejo; J Gavila; J García-Saenz; A Santaballa; P Martínez; A Llombart; R Andrés; N Batista; A Fernández; A Antón; M Seguí; S Gonzalez; A Ruiz
Journal:  Clin Transl Oncol       Date:  2019-08-05       Impact factor: 3.405

Review 6.  Searching for Clinically Relevant Biomarkers in Geriatric Oncology.

Authors:  Theodora Katsila; George P Patrinos; Dimitrios Kardamakis
Journal:  Biomed Res Int       Date:  2018-02-18       Impact factor: 3.411

7.  How aging of the global population is changing oncology.

Authors:  Yan Fei Gu; Frank P Lin; Richard J Epstein
Journal:  Ecancermedicalscience       Date:  2021-12-13

8.  Impact of age on the cumulative risk of transformation in patients with chronic myelomonocytic leukaemia.

Authors:  Sigrid Machherndl-Spandl; Eva Jäger; Agnes Barna; Michael Gurbisz; Renate Marschon; Temeida Graf; Elmir Graf; Christoph Geissler; Gregor Hoermann; Thomas Nösslinger; Michael Pfeilstöcker; Peter Bettelheim; Otto Zach; Ansgar Weltermann; Sonja Heibl; Josef Thaler; Armin Zebisch; Heinz Sill; Reinhard Stauder; Gerald Webersinke; Rajko Kusec; Ernst Ulsperger; Bruno Schneeweiss; Leopold Öhler; Ulrich Germing; Peter Valent; Heinz Tüchler; Klaus Geissler
Journal:  Eur J Haematol       Date:  2021-06-01       Impact factor: 2.997

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.